Navigation Links
Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis
Date:6/2/2008

TSX Venture: QPT

EDMONTON, June 2 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company"), today announced that its 12-patient, Phase I clinical study entitled "ACP-SL017 Topical Gel: A Phase I Study for the Photodynamic Therapy of Actinic Keratosis" has met both its primary and exploratory objectives.

"We are delighted to have received, for the first time, clinical validation for our SonoLight Technology in a dermatological application," said Madi R. Madiyalakan, CEO of Quest. "Actinic Keratosis is a pre-cancerous skin condition usually caused by prolonged accumulated sun exposure which can progress to squamous cell carcinoma, a potentially life-threatening form of skin cancer, unless treated by a dermatologist or other physician. This trial successfully demonstrated that cutaneous photodynamic therapy (PDT) with SL017 appears safe and is well tolerated. In addition, our unique approach is designed to overcome some of the limitations associated with other commercially available PDT treatments for Actinic Keratosis."

Actinic Keratosis has a global incidence of approximately 10 to 15% in the Caucasian population and the American Medical Association estimates the U.S. market for the treatment of Actinic Keratosis to be about US $250 million.

The primary objective of the Phase I study, which was conducted in Canada, was to determine the cutaneous and systemic toxicity of the topically-applied photoactive drug, SL017, with and without photoactivation. The exploratory objective was to evaluate the efficacy of SL017 with and without photoactivation in the treatment of Actinic Keratosis. The study parameters employed included physician clinical assessment, patient symptomatic assessment, skin photography, blood chemistry, urinalysis, electrocardiogram and skin biopsy. The study was conducted at clinical sites in Edmonton and Montreal.

The study met all the objectives address
'/>"/>

SOURCE Quest PharmaTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
3. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
4. VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
5. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
6. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
7. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Mass., Nov. 6 Myriant Technologi...loper and manufacturer of renewable bio-chemicals...chnology provider Uhde GmbH, one of the world,s le...nounced an alliance for the engineering, procureme...Succinic Acid plants based on renewable feedstocks...
(Date:11/6/2009)... VALLEY, Calif., Nov. 6 Calbiotech...Small Business Innovative Research (SBIR) Phase I ...erial command. Under terms of the agreement, Calbi...) for the diagnosis of Dengue virus. ,, Deng...ents a major threat to military forces deployed to...
(Date:11/6/2009)... The agenda for Arrowhead’s 201...hich is set to take place on February 22-24, 2010 ... day conference we will highlight key issues in fo... share their experiences. , ... agenda for Arrowhead’s 2010 Personalized M...
(Date:11/5/2009)...GTON, Colo., Nov. 5 The endangered... the western U.S. This rare carnivore feeds on pr...e to plague and often entire population die-offs i...ce (FWS) has implemented a ferret breeding program...nto their formerly native habitat. Unfortunately,...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
... Initiative, Based on Advanced WiMAX Broadband Wir...ss to Kindergartens, Elementary Schools and the ...ACH TIKVA, Israel, January 8 012,Smile.Communicat...d provider,of communication services in Israel, to...istry of Communications, Intel Corporation (NYSE: ...
...ISON, N.J., Jan. 7 Quest Diagnostics,Incorporated...iagnostic,testing, information and services, annou...ual JPMorgan Healthcare Conference on Tuesday, Jan...cisco, California. The Quest,Diagnostics presentat...me., The presentation will be webcast live during...
...RENCE, Mass., Jan. 7 NxStage Medical, Inc.,(Nasda...ialysis products,today announced that it has signe...DVA ) to continue to supply DaVita,s dialysis cent...sets, subject to certain terms and,conditions. Saf...patients,blood during the vast majority of chronic...
Other Biology Technology:Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 2Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 3Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 4Israel's Ministry of Communications, 012 Smile.Communications, Intel and Alvarion Join in Launching WiMAX Initiative for Sderot, a City in the Western Negev 5Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference 2NxStage Medical Announces Needle Supply Agreement with DaVita 2
(Date:11/8/2009)...v. 8, 2009) The loss of a gene through deletion o...with significant abnormalities in learning and beh...lor College of Medicine ( www.bcm.edu ) in a repor... Genetics . , "This research goes about 95 perce...fic group of individuals to this gene," said Dr. A...
(Date:11/6/2009)...stration is now open for the Society of Interventi...logy (IO) Therapies" Webinar, which will provide t...r treatment of liver tumors, kidney tumor ablation...zation of physicians, scientists and allied health...h through pioneering advances in image-guided ther...
(Date:11/6/2009)...ts generally live in harmony with their arboreal h... out of space in their trees of choice, the ants c...esearch, published in the November issue of the A... ants bore into live trees, and it reopens a centu...nd plants. , Ants and certain species of plants ...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Ants are friendly to some trees, but not others 2Bolton School of Nursing at CWRU receives 243 7 million in federal stimulus funding 59933 1Bolton School of Nursing at CWRU receives 243 7 million in federal stimulus funding 59933 2Radiation Treatments Made Safer for Cancer Patients 59930 1Radiation Treatments Made Safer for Cancer Patients 59930 2Senetek Implements New Corporate Communication Policy 59927 1Senetek Implements New Corporate Communication Policy 59927 2
...on system developed by Carnegie Mellon University ...ama Desert, according to results being presented a...March 14-18 in Houston. This marks the first time ...o identify life in this harsh region, which serves...ed in future Mars missions. , "Our life detection ...
...like "water balloons" composed of artificially cre... membranes ?have revealed unexpected behavior in t...a paradigm-shifting change in science,s understand...stems. , Arizona State University chemists Mark Ha...ave a tendency to form tube-like extensions in the...
...unodeficiency virus (HIV), highly active antiretro...s of Kaposi sarcoma and non-Hodgkin lymphoma, acco...Journal of the National Cancer Institute. , Studie...e (AIDS) have reported increased risks of several ...phoma, and, to a lesser extent, anal cancer, invas...
Other Biology News:Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 2Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 3Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 4Antiretroviral therapy may prevent excess risk of some cancers in people with HIV 2
Qplate from Sophion Bioscience
...ftware, a multitasking application capable of dyna...g and operation of lab automation workcells easy f...odification by programmers. • Users create ...t. If you can build a flowchart, you can write a S...
...demands continue to grow, the need for greater det...e necessary, especially when discerning very simil...ve C1si Confocal Microscope System gives you a lev...ot available in conventional confocal systems, wit...
...sed assay kit provides complete components includi...ent detection of DNA fragmentation in cultured cel...in the procedure provides greater sensitivity than...can be analyzed by fluorescence microscopy or flow...
Biology Products: